SIM
AEON icon

Sandia Investment Management’s AEON Biopharma AEON Stock Holding History

Sandia Investment Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,627
Closed -$1.17M – 217
2023
Q2 		$1.17M Sell
1,627
-185
-10% -$130K 0.26% 81
2023
Q1 		$1.32M Buy
+1,812
New +$1.31M 0.24% 94

Other funds holding AEON

ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sandia Investment Management's AEON Position: Q3 2023 in Review

Sandia Investment Management sold out of AEON Biopharma (AEON) in Q3 2023, closing a stake of 1,627 shares — an estimated $1.17M sold.

Sandia Investment Management first reported a position in AEON in Q1 2023 and held it in 2 quarters. The position peaked at $1.32M in Q1 2023. 15 funds tracked by Wall St. Rank hold AEON as of Q3 2023.

  • Sandia Investment Management reported no remaining AEON Biopharma position as of Q3 2023 after selling out during the quarter.
  • Sandia Investment Management sold 1,627 AEON Biopharma shares in Q3 2023, an estimated $1.17M.
  • Sandia Investment Management first reported a position in AEON Biopharma in Q1 2023 and held it in 2 quarters.
  • Sandia Investment Management's AEON Biopharma position peaked at $1.32M in Q1 2023.
  • 15 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2023.

Based on Sandia Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.